Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 1725 of 2529 entries
View as:

An Efficacy, Safety, Tolerability and Dose Finding Study of XXB750 in Resistant Hypertension Patients.

Phase: N/A Priority: Normal
NCT ID: NCT05562934 Org: User:
Start: 11/08/22 End: 08/27/24 Due: 08/27/25

Study of Efficacy and Safety of Secukinumab in Participants With Moderate-severe Rotator Cuff Tendinopathy

Phase: N/A Priority: Normal
NCT ID: NCT05758415 Org: User:
Start: 08/02/23 End: 12/11/24 Due: 12/11/25

PHE885 CAR-T Therapy in Adult Participants With Relapsed and Refractory Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT05172596 Org: User:
Start: 03/03/22 End: 05/21/25 Due: 05/21/26

Activity, Safety and Pharmacokinetics in Pediatric Subjects With Moderate and Severe Chronic Graft vs. Host Disease After Allogeneic Stem Cell Transplant

Phase: N/A Priority: Normal
NCT ID: NCT03774082 Org: User:
Start: 05/20/20 End: 08/26/24 Due: 08/26/25

Rollover Study for Continued Safety and Tolerability in Subjects Treated With Spartalizumab Alone or in Combination With Other Study Treatments

Phase: N/A Priority: Normal
NCT ID: NCT04058756 Org: User:
Start: 10/30/19 End: 04/30/30 Due: 04/30/31

Safety and Efficacy of QAX576 in Patients With Idiopathic Pulmonary Fibrosis (IPF)

Phase: N/A Priority: Normal
NCT ID: NCT01266135 Org: User:
Start: 12/31/10 End: 04/30/13 Due: 04/30/14

Effect of an Individualized Patient Support Program on Treatment Satisfaction in Fingolimod-treated Patients With RRMS

Phase: N/A Priority: Normal
NCT ID: NCT01709812 Org: User:
Start: 07/31/13 End: 07/31/13 Due: 07/31/14

Glivec/Gleevec Pediatric (Age 1 to Less Than 4) PK Study in CML, Ph+ ALL Patients and Other Glivec/Gleevec® Indicated Hematological Disorders.

Phase: N/A Priority: Normal
NCT ID: NCT01066468 Org: User:
Start: 10/31/10 End: - Due: -

Phase I Study of MIK665, a Mcl-1 Inhibitor, in Patients With Refractory or Relapsed Lymphoma or Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT02992483 Org: User:
Start: 07/12/17 End: 06/07/19 Due: 06/07/20

Comparison Trial of Letrozole to Anastrozole in the Adjuvant Treatment of Postmenopausal Women With Hormone Receptor and Node Positive Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00248170 Org: User:
Start: 12/31/05 End: 09/30/14 Due: 09/30/15

Changes in NT-proBNP, Safety, and Tolerability in HFpEF Patients With a WHF Event (HFpEF Decompensation) Who Have Been Stabilized and Initiated at the Time of or Within 30 Days Post-decompensation (PARAGLIDE-HF)

Phase: N/A Priority: Normal
NCT ID: NCT03988634 Org: User:
Start: 06/29/19 End: 12/14/22 Due: 12/14/23

Study of Efficacy and Safety of AIN457/Secukinumab in Patients With Rotator Cuff Tendinopathy

Phase: N/A Priority: Normal
NCT ID: NCT05569174 Org: User:
Start: 12/02/22 End: 12/18/24 Due: 12/18/25

Intravascular Imaging Study of the Effect of Inclisiran on Plaque in Patients With Acute Myocardial Infarction

Phase: N/A Priority: Normal
NCT ID: NCT06372925 Org: User:
Start: 07/12/24 End: 06/24/26 Due: 06/24/27

A Study of Ribociclib in Combination With Hormonal Therapy in HR+/HER2- Advanced or Metastatic Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06075758 Org: User:
Start: 03/07/24 End: 06/30/25 Due: 06/30/26

A Placebo-controlled Study of Efficacy & Safety of 2 Trough-ranges of Everolimus as Adjunctive Therapy in Patients With Tuberous Sclerosis Complex (TSC) & Refractory Partial-onset Seizures

Phase: N/A Priority: Normal
NCT ID: NCT01713946 Org: User:
Start: 04/29/13 End: 10/25/17 Due: 10/25/18

Efficacy and Safety of Enteric-coated Mycophenolate Sodium in Combination With Two Corticosteroid Regimens for the Treatment of Lupus Nephritis Flare

Phase: N/A Priority: Normal
NCT ID: NCT00423098 Org: User:
Start: 02/28/07 End: 11/30/09 Due: 11/30/10

Pharmacokinetic Study of BKM120 in Subjects With Hepatic Impairment

Phase: N/A Priority: Normal
NCT ID: NCT01727128 Org: User:
Start: 10/31/11 End: 08/31/13 Due: 08/31/14

MAP to Provide Access to Nilotinib, for Patients With Relapsed or Refractory Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT04559555 Org: User:
Start: - End: - Due: -

Letrozole in the Treatment of Advanced or Recurrent Hormone Receptor Positive Endometrial Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00171808 Org: User:
Start: 04/30/05 End: - Due: -

Trial Evaluating Dovitinib Combined With Fulvestrant, in Postmenopausal Patients With HER2- and HR+ Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01528345 Org: User:
Start: 04/30/12 End: 04/30/15 Due: 04/30/16

An Extension Study to Evaluate the Long Term Safety, Tolerability and Efficacy of Aliskiren Compared to Enalapril in Pediatric Hypertensive Patients 6-17 Years of Age

Phase: N/A Priority: Normal
NCT ID: NCT01151410 Org: User:
Start: 08/31/10 End: 08/31/15 Due: 08/31/16

Single Agent Ofatumumab Vs. Single Agent Rituximab in Indolent B-Cell Non Hodgkin Lymphoma Relapsed After Rituximab-Containing Therapy

Phase: N/A Priority: Normal
NCT ID: NCT01200589 Org: User:
Start: 10/11/10 End: 12/19/16 Due: 12/19/17

HDM201 Added to CT in R/R or Newly Diagnosed AML

Phase: N/A Priority: Normal
NCT ID: NCT03760445 Org: User:
Start: 11/15/19 End: 06/13/23 Due: 06/13/24

Real-world Evaluation of Prevalence of Ocular Adverse Events in Patients With Neovascular (Wet) Agerelated Macular Degeneration (AMD) Who Received Anti-VEGF Agents (IRIS Registry)

Phase: N/A Priority: Normal
NCT ID: NCT05110209 Org: User:
Start: 07/15/20 End: 11/20/20 Due: 11/20/21

Long-term Safety, Tolerability and Efficacy of BAF312 Given Orally in Patients With Relapsing-remitting Multiple Sclerosis

Phase: N/A Priority: Normal
NCT ID: NCT01185821 Org: User:
Start: 08/30/10 End: 10/10/16 Due: 10/10/17